# A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System

> **NCT05975619** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Varian, a Siemens Healthineers Company** · enrollment: 40 (estimated)

## Conditions studied

- Head and Neck Cancer
- Thoracic Cancer
- Abdominal Cancer
- Pelvic Cancer

## Interventions

- **DEVICE:** HyperSight imaging

## Key facts

- **NCT ID:** NCT05975619
- **Lead sponsor:** Varian, a Siemens Healthineers Company
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-29
- **Primary completion:** 2025-03-24
- **Final completion:** 2026-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05975619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05975619, "A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05975619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*